Last reviewed · How we verify
Placebo (for aflibercept)
Placebo (for aflibercept) is a Small molecule drug developed by Sanofi. It is currently in Phase 3 development for Comparison control in clinical trials for aflibercept.
Placebo does not have a known mechanism of action.
Placebo does not have a known mechanism of action. Used for Comparison control in clinical trials for aflibercept.
At a glance
| Generic name | Placebo (for aflibercept) |
|---|---|
| Sponsor | Sanofi |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a placebo, it does not contain any active pharmaceutical ingredient and therefore does not have a known mechanism of action. It is used as a control in clinical trials to compare the efficacy of active treatments.
Approved indications
- Comparison control in clinical trials for aflibercept
Common side effects
Key clinical trials
- Comparative Multicenter Randomized Study of Aflibercept Versus Placebo in Macular Telangiectasia Type 1 (PHASE3)
- IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD (PHASE2)
- A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (PHASE3)
- Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion (PHASE3)
- Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion (PHASE3)
- A Study to Assess the Efficacy and Safety of AKST4290 With Aflibercept in Patients With Newly Diagnosed nAMD (PHASE2)
- X-82 to Treat Age-related Macular Degeneration (PHASE2)
- FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo (for aflibercept) CI brief — competitive landscape report
- Placebo (for aflibercept) updates RSS · CI watch RSS
- Sanofi portfolio CI
Frequently asked questions about Placebo (for aflibercept)
What is Placebo (for aflibercept)?
How does Placebo (for aflibercept) work?
What is Placebo (for aflibercept) used for?
Who makes Placebo (for aflibercept)?
What development phase is Placebo (for aflibercept) in?
Related
- Manufacturer: Sanofi — full pipeline
- Indication: Drugs for Comparison control in clinical trials for aflibercept
- Compare: Placebo (for aflibercept) vs similar drugs
- Pricing: Placebo (for aflibercept) cost, discount & access